JPRN-UMIN000015121已完成未知
Study Of Patient risk factors for Febrile Neutropenia in NHL patients receiving (R)CHOP regimen - STOP FN in NH
The Cancer Institute Hospital Of JFCR0 个研究点目标入组 400 人开始时间: 2014年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
Refer to the article
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •HIV related H
研究者
相似试验
已完成
不适用
Study of patient risk factors for febrile neutropenia in NHL receiving (R)CHOP regimen 2on Hodgkin's LymphomaJPRN-UMIN000029534The Cancer Institute Hospital Of JFCR239
已完成
不适用
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical ProtocolSquamous Cell Head and Neck CarcinomaNCT01268878Groupe Oncologie Radiotherapie Tete et Cou130
已完成
不适用
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic ChemotherapyBreast CancerOvarian CancerNon-Small Cell Lung CancerSmall Cell Lung CancerNCT00883181Amgen1,370
已完成
不适用
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.Chemotherapy-induced Febrile NeutropeniaNCT01813721Amgen1,007
招募中
不适用
IL-8 study.- Pediatric cancer patients- Febrile neutropenia- Risk assessment model- Antibiotic treatmentNL-OMON21368niversity Medical Center of GroningenHanzeplein 19713 GZ Groningen270